Literature DB >> 9682918

Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states.

H C Gonick1, Y Ding, N D Vaziri, A Y Bagrov, O V Fedorova.   

Abstract

We have previously demonstrated that a 12 kD hypertension-associated protein (HAP) is elevated in essential hypertension and that this protein has the characteristics of natriuresis, inhibition of Na-K-ATPase, displaces 3H-ouabain from binding sites, and is vasoconstrictive in vitro. In the present study, plasma from 101 patients were examined [25 normals (N)<age 50, 13 N >age 50, 7 with acute congestive heart failure (CHF), 24 with chronic renal failure (CRF), on dialysis, 5 with idiopathic hyperaldosteronism (PA) and 27 with essential hypertension, untreated (EHT)]. Plasma was extracted with 32% acetonitrile, then analyzed by DELFIA for marinobufagenin and ouabain. In addition, from 32 patients (6 N <50, 6 N >50, 5 CHF, 5 CRF, 6 EHT, and 4 PA) SDS gradient gels were obtained. The 12 kD bands were extracted, analyzed for Na-K-ATPase inhibition, marinobufagenin and ouabain, and compared to 14 kD and 21 kD bands. Marinobufagenin was found to be elevated in CRF, EHT, PA and CHF. Ouabain was increased only in PA. When the relative optical densities of the 12 kD and 21 kD bands were contrasted, CRF, PA, and EHT were found to be increased and CHF to be decreased in the 12 kD band, with no discernible changes in the 21 kD bands. Following extraction of the bands, Na-K-ATPase inhibitory activity measured 38% in 18 pooled 12 kD bands, with essentially no activity found in the 14 kD or 21 kD bands. Thus only the 12 kD HAP band possessed all of the attributes of natriuretic hormone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682918     DOI: 10.3109/10641969809053240

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  33 in total

1.  Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure.

Authors:  David J Kennedy; Kevin Shrestha; Brendan Sheehey; Xinmin S Li; Anuradha Guggilam; Yuping Wu; Michael Finucan; Alaa Gabi; Charles M Medert; Kristen Westfall; Allen Borowski; Olga Fedorova; Alexei Y Bagrov; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2015-08-14       Impact factor: 8.790

Review 2.  An update on the relationship between the kidney, salt and hypertension.

Authors:  Gert Mayer
Journal:  Wien Med Wochenschr       Date:  2008

Review 3.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 4.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 5.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 6.  Hemodialysis-induced cardiovascular disease.

Authors:  Shadi Ahmadmehrabi; W H Wilson Tang
Journal:  Semin Dial       Date:  2018-04-06       Impact factor: 3.455

Review 7.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

8.  Cinobufotalin impedes Sw.71 cytotrophoblast cell line function via cell cycle arrest and apoptotic signaling.

Authors:  Syeda H Afroze; Jenna Sloan; Grace-Ann C Osuji; Nathan Drever; Kimberly Pilkinton; David C Zawieja; Thomas J Kuehl; M Nasir Uddin
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

9.  Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling.

Authors:  Mohammad N Uddin; Darijana Horvat; Ed W Childs; Jules B Puschett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-22       Impact factor: 3.619

10.  Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain.

Authors:  Fabiano E Xavier; Alvaro Yogi; Gláucia E Callera; Rita C Tostes; Yolanda Alvarez; Mercedes Salaices; María J Alonso; Luciana V Rossoni
Journal:  Br J Pharmacol       Date:  2004-10-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.